DAWN (Day One Biopharmaceuticals) OCF Yield %: -4.66 (As of Jun. 25, 2026)


DAWN Day One Biopharmaceuticals Inc DAWN
12 GF Score
Price $21.53
! 5 Warning Signs
View Full Analysis

What is Day One Biopharmaceuticals OCF Yield %?

Day One Biopharmaceuticals DAWN 12 OCF Yield % is -4.66 as of Jun. 25, 2026. GuruFocus rates DAWN with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 1,418 Biotechnology companies, Day One Biopharmaceuticals ranks better than 59.45% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Day One Biopharmaceuticals's Trailing 12-Month Cash Flow from Operations is $-103.8 Mil, and Market Cap is $2,224.8 Mil. Therefore, Day One Biopharmaceuticals's OCF Yield % for today is -4.66%.

The historical rank and industry rank for Day One Biopharmaceuticals's OCF Yield % or its related term are showing as below:

DAWN' s OCF Yield % Range Over the Past 10 Years
Min: -16.07   Med: -9.27   Max: -4.65
Current: -4.66

During the past 7 years, the highest OCF Yield % of Day One Biopharmaceuticals was -4.65%. The lowest was -16.07%. And the median was -9.27%.

DAWN's OCF Yield % is ranked better than
59.45% of 1418 companies
in the Biotechnology industry
Industry Median: -8.55 vs DAWN: -4.66

Day One Biopharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2025 was %.

Day One Biopharmaceuticals OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Day One Biopharmaceuticals OCF Yield % Related Terms

Day One Biopharmaceuticals OCF Yield % Historical Data

* Premium members only.

The historical data trend for Day One Biopharmaceuticals's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Day One Biopharmaceuticals OCF Yield % Chart

Day One Biopharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -4.65 -6.95 -11.53 -6.10 -10.81

Day One Biopharmaceuticals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.37 -29.36 -14.90 -3.21 -5.90

DAWN vs TYRA, DFTX, MLYS: OCF Yield % Comparison

For the Biotechnology subindustry, Day One Biopharmaceuticals's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Day One Biopharmaceuticals OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Day One Biopharmaceuticals's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Day One Biopharmaceuticals's OCF Yield % falls into.


DAWN
12GF Score
Day One Biopharmaceuticals Inc DAWN
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Day One Biopharmaceuticals OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Day One Biopharmaceuticals's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-103.757 / 959.80156
=-10.81%

Day One Biopharmaceuticals's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-14.149 * 4 / 959.80156
=-5.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -4.66 mean?
Day One Biopharmaceuticals (DAWN) has a OCF Yield % of -4.66 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Day One Biopharmaceuticals and its competitors. According to the industry distribution chart, Day One Biopharmaceuticals ranks #575 out of 1418 companies in the Biotechnology industry, placing it in the top 40.6%.
Is Day One Biopharmaceuticals' OCF Yield % too high?
Day One Biopharmaceuticals' current OCF Yield % is -4.66. Based on the distribution chart, Day One Biopharmaceuticals ranks #575 out of 1418 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Day One Biopharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Day One Biopharmaceuticals' OCF Yield % compare to TYRA and DFTX?
According to the Biotechnology industry distribution chart, Day One Biopharmaceuticals ranks #575 out of 1418 companies for OCF Yield %. This puts Day One Biopharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Day One Biopharmaceuticals and its competitors. Day One Biopharmaceuticals's current OCF Yield % is -4.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Day One Biopharmaceuticals stock overvalued right now?
Day One Biopharmaceuticals (DAWN) has a current OCF Yield % of -4.66. The current OCF Yield % is -4.66. Day One Biopharmaceuticals' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Day One Biopharmaceuticals (DAWN), the current OCF Yield % is -4.66 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Day One Biopharmaceuticals Business Description

Address 1800 Sierra Point Parkway, Suite 200, Brisbane, CA, USA, 94005
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
12GF Score

Get the complete analysis for DAWN

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.53
Price